Breast cancer in a male-to-female transsexual patient with a BRCA2 mutation
- 1 May 2016
- journal article
- case report
- Published by Bioscientifica in Endocrine-Related Cancer
- Vol. 23 (5), 391-397
- https://doi.org/10.1530/erc-16-0057
Abstract
Breast cancer is rare in male patients. Certain predisposing factors, be they genetic (e.g., BRCA2 gene mutations) or hormonal (imbalance between estrogen and androgen levels), have been implicated in male breast cancer pathophysiology. Male-to-female (MtF) transsexualism is a condition that generally involves cross-sex hormone therapy. Anti-androgens and estrogens are used to mimic the female hormonal environment and induce the cross-sex secondary characteristics. In certain situations, the change in the hormonal milieu can be disadvantageous and favor the development of hormone-dependent pathologies, such as cancer. We report a case of a MtF transgender patient who developed breast cancer after 7 years of cross-sex hormonal therapy. The patient was found to be BRCA2 positive, and suffered recurrent disease. The patient was unaware of being a member of an established BRCA2 mutation-positive kindred. This represents the first case of a BRCA2 mutation predisposing to breast cancer in a MtF transgender patient.Keywords
This publication has 35 references indexed in Scilit:
- Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACEJNCI Journal of the National Cancer Institute, 2013
- Comprehensive splicing functional analysis of DNA variants of the BRCA2 gene by hybrid minigenesBreast Cancer Research, 2012
- BRCA in breast cancer: ESMO Clinical Practice GuidelinesAnnals of Oncology, 2011
- Androgen receptor expression in breast cancer patients tested for BRCA1 and BRCA2 mutationsHistopathology, 2010
- Examining Patient Conceptions: A Case of Metastatic Breast Cancer in an African American Male to Female Transgender PatientJournal of General Internal Medicine, 2009
- Prospective Evaluation of Risk Factors for Male Breast CancerJNCI Journal of the National Cancer Institute, 2008
- Male breast cancerThe Lancet, 2006
- Two Percent of Men with Early-Onset Prostate Cancer Harbor Germline Mutations in the BRCA2 GeneAmerican Journal of Human Genetics, 2003
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995
- Breast cancer in a trans-sexual man receiving hormone replacement therapyBritish Journal of Surgery, 1995